For instance, the synthesized LRP1 agonist (SP16) has been found to rapidly induce Akt phosphorylation, exert anti-inflammatory effects, and inhibit programmed death of myocardial cells, thereby protecting the surviving myocardium adjacent to the infarction scar (3–5). This evidence concerns the gene LRP1 and infarction.